DARZALEX® Dosing

Share

How Is DARZALEX® Given?

How Is DARZALEX® Given?

DARZALEX® is administered by a healthcare professional as an intravenous (IV) infusion into your vein. DARZALEX® may be given alone or together with other medicines used to treat multiple myeloma.

  • Your healthcare professional will determine your dose of DARZALEX® according to your body weight
  • Your healthcare professional will decide the time between doses based on what DARZALEX®  treatment you will receive
  • If you miss any appointments, call your healthcare professional as soon as possible to reschedule your appointment

 

 

Watch a video about what to expect before, during, and after DARZALEX® treatment

To view Important Product Information, please click here.

 

How Often Is DARZALEX® Given?

Dosing frequency of DARZALEX® in combination with Revlimid® (lenalidomide) + dexamethasone and as a monotherapy

 

Dosing frequency of DARZALEX® in combination with Velcade® (bortezomib) + dexamethasone 

 

My Treatment Schedule

Depending on where you are in your treatment journey, your doctor may discuss treatment with DARZALEX® as a monotherapy or a combination therapy.

Select the date on which you expect to receive your first DARZALEX® treatment. Once a date is selected, recommended subsequent treatment dates will automatically populate within the calendar.*

Tap a date to begin.
My Treatment Schedule

Depending on where you are in your treatment journey, your doctor may discuss treatment with DARZALEX® as a monotherapy or a combination therapy.

Select the date on which you expect to receive your first DARZALEX® treatment. Once a date is selected, recommended subsequent treatment dates will automatically populate within the calendar.*

Tap a date below to begin.

Infusion Dates
Weeks 1-8
Weekly Infusions
Weeks 1-8 (weekly infusions)
Weeks 9-24
Infusions Every 2 Weeks
Weeks 9-24 (infusions every 2 weeks)
Weeks 25+
Infusions Every 4 Weeks
Weeks 25+ (infusions every 4 weeks)

*Please note that dates provided are recommendations for infusion visits only. Your doctor is likely to schedule additional follow-up/care visits and may alter the dates for your infusions depending on your availability and office availability.

Infusion centers may not offer weekend and/or holiday appointments.

Please contact the center to confirm hours of operation.

You have chosen a new start date.

Would you like to clear your old dosing schedule and create a new one?

Please select the date you plan to receive your first DARZALEX® dose.
Please choose a dosing regimen.
DARZALEX® Monotherapy
DARZALEX® + lenalidomide + dexamethasone
DARZALEX® + bortezomib + dexamethasone
Choose PDF type

Please select the view mode for your dosing calendar.

Want a PDF of this treatment schedule?

Learn about some useful tips to help you prepare for your infusions and feel comfortable during your appointments.

    Revlimid® is a registered trademark of Celgene Corporation. Velcade® is a registered trademark of Millennium Pharmaceuticals, Inc.